Fondaparinux
Back to searchMolecule Structure
Scientific Name
Fondaparinux
Description of the Drug
Fondaparinux is an anticoagulant used to prevent venous thromboembolism, to treat deep vein thrombosis, and to improve survival following myocardial infarction.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00569
http://www.drugbank.ca/drugs/DB00569
Brand Name(s)
Not Available
Company Owner(s)
Mylan Ireland Ltd, Scinopharm Taiwan Ltd, Eugia Pharma Specialities Ltd, Dr Reddys Laboratories Ltd, Jiangsu Hengrui Pharmaceuticals Co Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Antithrombin-III | SINGLE PROTEIN | ACTIVATOR | CHEMBL1950 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL17655218 | ||
| Human Metabolome Database | HMDB0014709 | ||
| DrugBank | DB00569 | ||
| PubChem: Thomson Pharma | 14792964 | ||
| PubChem | 5282448 | ||
| Nikkaji | J862.320A | ||
| BindingDB | 50511579 | ||
| EPA CompTox Dashboard | DTXSID10146903 | ||
| DrugCentral | 1236 | ||
| Brenda | 167802 | 117819 | |
| Guide to Pharmacology | 6819 | ||
| rxnorm | ARIXTRA | FONDAPARINUX | FONDAPARINUX SODIUM |
| ChEBI | 61033 |
